全文获取类型
收费全文 | 1102篇 |
免费 | 70篇 |
专业分类
电工技术 | 4篇 |
化学工业 | 436篇 |
金属工艺 | 6篇 |
机械仪表 | 25篇 |
建筑科学 | 37篇 |
矿业工程 | 1篇 |
能源动力 | 38篇 |
轻工业 | 291篇 |
水利工程 | 3篇 |
石油天然气 | 4篇 |
无线电 | 46篇 |
一般工业技术 | 169篇 |
冶金工业 | 15篇 |
原子能技术 | 2篇 |
自动化技术 | 95篇 |
出版年
2024年 | 3篇 |
2023年 | 12篇 |
2022年 | 89篇 |
2021年 | 98篇 |
2020年 | 33篇 |
2019年 | 35篇 |
2018年 | 38篇 |
2017年 | 39篇 |
2016年 | 43篇 |
2015年 | 40篇 |
2014年 | 51篇 |
2013年 | 72篇 |
2012年 | 71篇 |
2011年 | 76篇 |
2010年 | 78篇 |
2009年 | 62篇 |
2008年 | 55篇 |
2007年 | 44篇 |
2006年 | 38篇 |
2005年 | 27篇 |
2004年 | 23篇 |
2003年 | 22篇 |
2002年 | 28篇 |
2001年 | 11篇 |
2000年 | 5篇 |
1999年 | 9篇 |
1998年 | 16篇 |
1997年 | 6篇 |
1996年 | 9篇 |
1995年 | 7篇 |
1994年 | 5篇 |
1993年 | 6篇 |
1992年 | 5篇 |
1991年 | 1篇 |
1990年 | 1篇 |
1989年 | 1篇 |
1988年 | 1篇 |
1987年 | 2篇 |
1986年 | 1篇 |
1985年 | 1篇 |
1984年 | 2篇 |
1983年 | 1篇 |
1982年 | 1篇 |
1979年 | 1篇 |
1978年 | 2篇 |
1961年 | 1篇 |
排序方式: 共有1172条查询结果,搜索用时 0 毫秒
981.
982.
Giordano Rampioni Fabio Mavelli Luisa Damiano Francesca D’Angelo Marco Messina Livia Leoni Pasquale Stano 《Natural computing》2014,13(3):333-349
In this article we present novel aspects of the impact that synthetic biology (SB) can express in a field traditionally based on computer science: information and communication technologies (ICTs), an area that we will consider taking into account also possible implications for artificial intelligence (AI) research. In the first part of this article we will shortly introduce some recent theoretical and experimental issues related to our approach in SB, discussing their relevance and potentiality in the field. Next, we define an original SB research programme that aims at contributing to the development of bio-chem-ICTs and AI based on chemical communication between natural and synthetic cells. In particular we present (i) a mathematical model that allows us to simulate the main features of the system under construction; and (ii) preliminary wet-lab experiments showing the feasibility of our research programme. Based on the bottom-up construction of synthetic cells, the traits of this novel approach and their connections with recent conceptual and technological trends are finally discussed. 相似文献
983.
984.
Organic Electronics: Stable Alignment of Tautomers at Room Temperature in Porphyrin 2D Layers (Adv. Funct. Mater. 7/2014) 下载免费PDF全文
985.
Francesco Vieceli Dalla Sega Francesca Fortini Paolo Cimaglia Luisa Marracino Elisabetta Tonet Antonio Antonucci Marco Moscarelli Gianluca Campo Paola Rizzo Roberto Ferrari 《International journal of molecular sciences》2020,21(23)
Calcific aortic valve disease (CAVD) is the result of maladaptive fibrocalcific processes leading to a progressive thickening and stiffening of aortic valve (AV) leaflets. CAVD is the most common cause of aortic stenosis (AS). At present, there is no effective pharmacotherapy in reducing CAVD progression; when CAVD becomes symptomatic it can only be treated with valve replacement. Inflammation has a key role in AV pathological remodeling; hence, anti-inflammatory therapy has been proposed as a strategy to prevent CAVD. Cyclooxygenase 2 (COX-2) is a key mediator of the inflammation and it is the target of widely used anti-inflammatory drugs. COX-2-inhibitor celecoxib was initially shown to reduce AV calcification in a murine model. However, in contrast to these findings, a recent retrospective clinical analysis found an association between AS and celecoxib use. In the present study, we investigated whether variations in COX-2 expression levels in human AVs may be linked to CAVD. We extracted total RNA from surgically explanted AVs from patients without CAVD or with CAVD. We found that COX-2 mRNA was higher in non-calcific AVs compared to calcific AVs (0.013 ± 0.002 vs. 0.006 ± 0.0004; p < 0.0001). Moreover, we isolated human aortic valve interstitial cells (AVICs) from AVs and found that COX-2 expression is decreased in AVICs from calcific valves compared to AVICs from non-calcific AVs. Furthermore, we observed that COX-2 inhibition with celecoxib induces AVICs trans-differentiation towards a myofibroblast phenotype, and increases the levels of TGF-β-induced apoptosis, both processes able to promote the formation of calcific nodules. We conclude that reduced COX-2 expression is a characteristic of human AVICs prone to calcification and that COX-2 inhibition may promote aortic valve calcification. Our findings support the notion that celecoxib may facilitate CAVD progression. 相似文献
986.
Blendi Ura Fulvio Celsi Luisa Zupin Giorgio Arrigoni Ilaria Battisti Bartolomea Gaita Domenico Leonardo Grasso Eva Orzan Raffaella Sagredini Egidio Barbi Sergio Crovella 《International journal of molecular sciences》2020,21(23)
Recurrent acute otitis media (RAOM) in children is clinically defined as the occurrence of at least three episodes of acute otitis media over a course of 6 months. A further common pathological condition of interest in the context of pediatric otolaryngology is adenotonsillar hypertrophy (ATH), a common cause of obstructive sleep apnea syndrome. Aimed at unraveling the differential modulation of proteins in the two pathologies and at understanding the possible pathways involved in their onset, we analyzed the proteomic profile of the adenoids from 14 RAOM and ATH patients by using two-dimensional gel electrophoresis (2-DE) and mass spectrometry (MS). The 2-DE coupled with MS allowed us to identify 23 spots with significant (p-value < 0.05) changes in protein amount, recognizing proteins involved in neutrophil degranulation and glycolysis pathways. 相似文献
987.
Francesca Marini Francesca Giusti Francesco Tonelli Maria Luisa Brandi 《International journal of molecular sciences》2021,22(8)
Pancreatic neuroendocrine tumors (pNETs) are a rare group of cancers accounting for about 1–2% of all pancreatic neoplasms. About 10% of pNETs arise within endocrine tumor syndromes, such as Multiple Endocrine Neoplasia type 1 (MEN1). pNETs affect 30–80% of MEN1 patients, manifesting prevalently as multiple microadenomas. pNETs in patients with MEN1 are particularly difficult to treat due to differences in their growth potential, their multiplicity, the frequent requirement of extensive surgery, the high rate of post-operative recurrences, and the concomitant development of other tumors. MEN1 syndrome is caused by germinal heterozygote inactivating mutation of the MEN1 gene, encoding the menin tumor suppressor protein. MEN1-related pNETs develop following the complete loss of function of wild-type menin. Menin is a key regulator of endocrine cell plasticity and its loss in these cells is sufficient for tumor initiation. Somatic biallelic loss of wild-type menin in the neuroendocrine pancreas presumably alters the epigenetic control of gene expression, mediated by histone modifications and DNA hypermethylation, as a driver of MEN1-associated pNET tumorigenesis. In this light, epigenetic-based therapies aimed to correct the altered DNA methylation, and/or histone modifications might be a possible therapeutic strategy for MEN1 pNETs, for whom standard treatments fail. 相似文献
988.
Jos María Bastida Jos Ramn Gonzalez-Porras Jos Rivera María Luisa Lozano 《International journal of molecular sciences》2021,22(9)
In the last decade, improvements in genetic testing have revolutionized the molecular diagnosis of inherited thrombocytopenias (ITs), increasing the spectrum of knowledge of these rare, complex and heterogeneous disorders. In contrast, the therapeutic management of ITs has not evolved in the same way. Platelet transfusions have been the gold standard treatment for a long time. Thrombopoietin receptor agonists (TPO-RA) were approved for immune thrombocytopenia (ITP) ten years ago and there is evidence for the use of TPO-RA not only in other forms of ITP, but also in ITs. We have reviewed in the literature the existing evidence on the role of TPO-RAs in ITs from 2010 to February 2021. A total of 24 articles have been included, 4 clinical trials, 3 case series and 17 case reports. A total of 126 patients with ITs have received TPO-RA. The main diagnoses were Wiskott–Aldrich syndrome, MYH9-related disorder and ANKRD26-related thrombocytopenia. Most patients were enrolled in clinical trials and were treated for short periods of time with TPO-RA as bridging therapies towards surgical interventions, or other specific approaches, such as hematopoietic stem cell transplantation. Here, we have carried out an updated and comprehensive review about the efficacy and safety of TPO-RA in ITs. 相似文献
989.
Vernica Palma-Barqueros Nuria Revilla Ana Snchez Ana Zamora Cnovas Agustín Rodriguez-Aln Ana Marín-Quílez Jos Ramn Gonzlez-Porras Vicente Vicente María Luisa Lozano Jos María Bastida Jos Rivera 《International journal of molecular sciences》2021,22(9)
Platelets play a major role in hemostasis as ppwell as in many other physiological and pathological processes. Accordingly, production of about 1011 platelet per day as well as appropriate survival and functions are life essential events. Inherited platelet disorders (IPDs), affecting either platelet count or platelet functions, comprise a heterogenous group of about sixty rare diseases caused by molecular anomalies in many culprit genes. Their clinical relevance is highly variable according to the specific disease and even within the same type, ranging from almost negligible to life-threatening. Mucocutaneous bleeding diathesis (epistaxis, gum bleeding, purpura, menorrhagia), but also multisystemic disorders and/or malignancy comprise the clinical spectrum of IPDs. The early and accurate diagnosis of IPDs and a close patient medical follow-up is of great importance. A genotype–phenotype relationship in many IPDs makes a molecular diagnosis especially relevant to proper clinical management. Genetic diagnosis of IPDs has been greatly facilitated by the introduction of high throughput sequencing (HTS) techniques into mainstream investigation practice in these diseases. However, there are still unsolved ethical concerns on general genetic investigations. Patients should be informed and comprehend the potential implications of their genetic analysis. Unlike the progress in diagnosis, there have been no major advances in the clinical management of IPDs. Educational and preventive measures, few hemostatic drugs, platelet transfusions, thrombopoietin receptor agonists, and in life-threatening IPDs, allogeneic hematopoietic stem cell transplantation are therapeutic possibilities. Gene therapy may be a future option. Regular follow-up by a specialized hematology service with multidisciplinary support especially for syndromic IPDs is mandatory. 相似文献
990.
Luisa Chocarro Ester Blanco Miren Zuazo Hugo Arasanz Ana Bocanegra Leticia Fernndez-Rubio Pilar Morente Gonzalo Fernndez-Hinojal Miriam Echaide Maider Garnica Pablo Ramos Ruth Vera Grazyna Kochan David Escors 《International journal of molecular sciences》2021,22(10)
Lymphocyte activation gene 3 (LAG-3) is a cell surface inhibitory receptor with multiple biological activities over T cell activation and effector functions. LAG-3 plays a regulatory role in immunity and emerged some time ago as an inhibitory immune checkpoint molecule comparable to PD-1 and CTLA-4 and a potential target for enhancing anti-cancer immune responses. LAG-3 is the third inhibitory receptor to be exploited in human anti-cancer immunotherapies, and it is considered a potential next-generation cancer immunotherapy target in human therapy, right next to PD-1 and CTLA-4. Unlike PD-1 and CTLA-4, the exact mechanisms of action of LAG-3 and its relationship with other immune checkpoint molecules remain poorly understood. This is partly caused by the presence of non-conventional signaling motifs in its intracellular domain that are different from other conventional immunoregulatory signaling motifs but with similar inhibitory activities. Here we summarize the current understanding of LAG-3 signaling and its role in LAG-3 functions, from its mechanisms of action to clinical applications. 相似文献